Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
26 hedge funds and large institutions have $51.8M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 9 closing their positions.
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
24% less funds holding
Funds holding: 34 → 26 (-8)
49% less capital invested
Capital invested by funds: $102M → $51.8M (-$50.4M)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$1.64M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$676K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$53.5K |
| 4 |
PC
PointState Capital
New York
|
+$32.4K |
| 5 |
Renaissance Technologies
New York
|
+$16.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$1.09M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$669K |
| 3 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
-$305K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$94K |
| 5 |
Morgan Stanley
New York
|
-$68.3K |
CORV Hedge Fund Activity: Q1 2016 in Review
26 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2016, worth a combined $51.8M — down 49% from $102M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CORV and 1 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Clough Capital Partners, adding an estimated $1.64M. The largest seller was Turner Investments, cutting an estimated $1.09M.
- 26 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2016, down from 34 in Q4 2015.
- Funds reported $51.8M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2016, down 49% quarter-over-quarter.
- 1 fund opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2016 and 9 closed out, a net change of -8 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2016 was Clough Capital Partners, an estimated $1.64M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2016 was Turner Investments, an estimated $1.09M sold.
Based on aggregated 13F filings for Q1 2016.